Redsense Medical ABRDSNF -51.43%54 Interest Coverage is No Debt (1) as of Mar. 2026, which is 100% below its 10-year median of 5.81. GuruFocus rates RDSNF with a GF Score™ of 54/100 and a GF Value™ of $0.77. The stock has 5 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Redsense Medical AB ranks better than 99.57% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Redsense Medical AB's
Operating Income
for the
three
months ended in Mar. 2026 was $0.12 Mil. Redsense Medical AB's Interest Expense for the
three
months ended in Mar. 2026 was $0.00 Mil.
Redsense Medical AB has no debt.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Redsense Medical AB has no debt.
(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for Redsense Medical AB's Interest Coverage or its related term are showing as below:
RDSNF'
s Interest Coverage Range Over the Past 10 Years
Min: 5.81 Med: 5.81 Max: No Debt
Current: No Debt
RDSNF's Interest Coverage is ranked better than 99.57% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs RDSNF: No Debt
Redsense Medical AB (OTCPK:RDSNF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Redsense Medical AB Interest Coverage Related Terms
Redsense Medical AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Redsense Medical AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
RDSNF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Redsense Medical AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redsense Medical AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Redsense Medical AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Redsense Medical AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
Redsense Medical AB (RDSNF) has a Interest Coverage of No Debt (1) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Redsense Medical AB and its competitors. This is 83% below median its historical median of 5.81. Over the past decade, Redsense Medical AB's Interest Coverage has ranged from 5.81 to 10,000.00. According to the industry distribution chart, Redsense Medical AB ranks #2 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 0.40000000000001%.
Is Redsense Medical AB's Interest Coverage too high?
Redsense Medical AB's current Interest Coverage of No Debt (1) is 83% below median its 10-year median of 5.81. Over the past 10 years, this metric has ranged from a low of 5.81 to a high of 10,000.00. Based on the distribution chart, Redsense Medical AB ranks #2 out of 468 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Redsense Medical AB has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Redsense Medical AB ranks #2 out of 468 companies for Interest Coverage. This places Redsense Medical AB in the top 0% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 15.71. Historically, Redsense Medical AB's own Interest Coverage has ranged from 5.81 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Redsense Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redsense Medical AB's current Interest Coverage is No Debt (1), which is 83% below median its own 10-year median of 5.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current Interest Coverage of No Debt (1). The stock's GF Value™ is $0.77, compared to a current price of $0.51 — trading 33.8% below its estimated fair value. The current Interest Coverage is No Debt (1), which is 83% below median its 10-year median of 5.81. Redsense Medical AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current Interest Coverage is No Debt (1) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redsense Medical AB (RDSNF) Overvalued in 2026?
Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued.
The current stock price of $0.51 is trading 33.8% below its estimated GF Value™ of $0.77.
Key valuation signals for RDSNF:
Interest Coverage: No Debt (1) (83% below median its 10-year median of 5.81)
GF Value™: $0.77 vs. price of $0.51 (33.8% below fair value)
No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score
Get the complete analysis for RDSNF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RDSNF has been successfully added to your 
